SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
OSI Pharmaceuticals, Inc. Announces That It's Partner Roche Has Received Approval For Tarceva(R) in the European Union for Maintenance Use in Advanced Non-Small Cell Lung Cancer